ADUS241220P145000
- 0.00
- 0.000.00%
Addus HomeCare Newsroom
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $141
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $141
Addus HomeCare Analyst Ratings
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $136
RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS)
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $141
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Raises Target Price to $141
Addus HomeCare Price Target Raised to $145.00/Share From $143.00 by Stephens & Co.
Addus HomeCare Is Maintained at Outperform by RBC Capital
Addus HomeCare Analyst Ratings
Oppenheimer Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $145
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Cuts Target Price to $136
A Quick Look at Today's Ratings for Addus HomeCare(ADUS.US), With a Forecast Between $83 to $145
Barclays Maintains Addus HomeCare(ADUS.US) With Sell Rating, Maintains Target Price $83
Macquarie Maintains Addus HomeCare(ADUS.US) With Buy Rating
Macquarie Sticks to Their Buy Rating for Addus Homecare (ADUS)
Addus HomeCare Is Maintained at Outperform by Macquarie
Addus HomeCare Price Target Announced at $150.00/Share by Keybanc
Addus HomeCare Initiated With an Overweight at KeyBanc
Addus HomeCare Initiated With an Overweight at KeyBanc